Principal Street Partners, LLC reports 0.25% decrease in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Principal Street Partners, LLC
Latest Disclosed Ownership	124,527 shares
Latest Disclosed Value	$ 7,552,589

On May 15, 2026 - Principal Street Partners, LLC filed a 13F-HR form disclosing ownership of 124,527 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $6,527,705 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 124,841 shares of Bristol-Myers Squibb Company. This represents a change in shares of -0.25% during the quarter. The current value of the position is $5,906,316 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-15	2026-03-31	13F	BRISTOL MYERS SQUIBB	Common stock	110122108	124,527	-314	-0.25	7,553	12.16	1.2328
2026-02-17	2025-12-31	13F	BRISTOL MYERS SQUIBB	Common stock	110122108	124,841	250	0.20	6,734	19.83	1.1359
2025-11-14	2025-09-30	13F	BRISTOL MYERS SQUIBB	Common stock	110122108	124,591	-5,715	-4.39	5,619	-6.83	0.8968
2025-08-14	2025-06-30	13F	BRISTOL MYERS SQUIBB	Common stock	110122108	130,306	8,071	6.60	6,032	-19.10	0.5915
2025-05-15	2025-03-31	13F	BRISTOL MYERS SQUIBB	Common stock	110122108	122,235	1,967	1.64	7,455	9.60	1.3866
2025-02-18	2024-12-31	13F	BRISTOL MYERS SQUIBB	Common stock	110122108	120,268	2,053	1.74	6,802	11.22	1.3376
2024-11-13	2024-09-30	13F	BRISTOL MYERS SQUIBB	Common stock	110122108	118,215	-13,807	-10.46	6,116	11.57	1.0001
2024-08-14	2024-06-30	13F	BRISTOL MYERS SQUIBB	Common stock	110122108	132,022	-5,072	-3.70	5,483	-23.21	0.9820
2024-05-15	2024-03-31	13F	BRISTOL MYERS SQUIBB	Common stock	110122108	137,094	56,188	69.45	7,140	71.98	1.3496
2024-02-07	2023-12-31	13F	BRISTOL MYERS SQUIBB	Common stock	110122108	80,906	1,175	1.47	4,151	-10.29	1.0015
2023-11-01	2023-09-30	13F	BRISTOL MYERS SQUIBB	Common stock	110122108	79,731	5,076	6.80	4,628	-3.08	0.9168
2023-08-21	2023-06-30	13F/A-1	BRISTOL MYERS SQUIBB	Common stock	110122108	74,655	-3,290	-4.22	4,774	-11.63	1.1347
2023-08-15	2023-06-30	13F	BRISTOL MYERS SQUIBB	Common stock	110122108	77,945	0		5,402		1.3654
2023-05-11	2023-03-31	13F	BRISTOL MYERS SQUIBB	Common stock	110122108	77,945	2,222	2.93	5,402	-0.84	1.3654
2023-02-15	2022-12-31	13F	BRISTOL MYERS SQUIBB	Common stock	110122108	75,723	540	0.72	5,448	1.93	1.3728
2022-11-14	2022-09-30	13F	BRISTOL MYERS SQUIBB	Common stock	110122108	75,183	-2,112	-2.73	5,345	-10.20	1.4245
2022-08-15	2022-06-30	13F	BRISTOL MYERS SQUIBB	Common stock	110122108	77,295	-16,581	-17.66	5,952	-13.19	1.5419
2022-05-05	2022-03-31	13F	Bristol Myers Squibb	Common stock	110122108	93,876	5,176	5.84	6,856	23.98	1.5719
2022-02-07	2021-12-31	13F	Bristol Myers Squibb	Common stock	110122108	88,700	13,730	18.31	5,530	24.66	1.3311
2021-11-10	2021-09-30	13F	Bristol Myers Squibb	Common stock	110122108	74,970	-2,419	-3.13	4,436	-14.21	1.2085
2021-08-10	2021-06-30	13F	Bristol Myers Squibb	Common stock	110122108	77,389	-117,340	-60.26	5,171	-57.94	1.3642
2021-05-13	2021-03-31	13F	Bristol Myers Squibb	Common stock	110122108	194,729	122,296	168.84	12,294	173.63	1.5865
2021-02-16	2020-12-31	13F	Bristol Myers Squibb	Common stock	110122108	72,433	-6,560	-8.30	4,493	-5.65	1.3761
2020-11-12	2020-09-30	13F	Bristol Myers Squibb	Common stock	110122108	78,993	-6,582	-7.69	4,762	-5.37	1.6731
2020-08-14	2020-06-30	13F	Bristol Myers Squibb	Common stock	110122108	85,575	-32,176	-27.33	5,032	-23.33	1.8797
2020-05-14	2020-03-31	13F	Bristol-Myers Squibb	Common stock	110122108	117,751	-39,537	-25.14	6,563	-34.99	2.7547
2020-03-04	2019-12-31	13F	Bristol-Myers Squibb	Common stock	110122108	157,288	6,295	4.17	10,096	31.85	2.2499
2019-11-14	2019-09-30	13F	BRISTOL MYERS SQUIBB CO COM	Common stock	110122108	150,993	150,993		7,657		1.9173

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.